Dendreon’s Drop: Buying Opportunity or Sign of Things to Come
Dendreon Corporation (NASDAQ: DNDN) shares fell more than 60% mid-way through Thursday’s session, after the biotechnology company withdrew its 2011 revenue guidance. While the company cited the adop.....
No comments:
Post a Comment